Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

  • Bowtell D.D.a b Böhm S
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015. © 2015 Macmillan Publishers Limited. All rights reserved.

Author-supplied keywords

  • antiangiogenic activity; cancer incidence; cancer

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • S.c Ahmed A.A.d Aspuria P.-J.e Bast R C Jr.f Beral V.g Berek J.S.h Birrer M.J.i Blagden S.j Bookman M.A.k Brenton J.D.l Chiappinelli K.B.m Martins F.C.l Coukos G.n Drapkin R.o Edmondson R.p Fotopoulou C.j Gabra H.j Galon J.q Gourley C.r Heong V.s Huntsman Bowtell D.D.a b Böhm

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free